| Dec'18 | Dec'17 | Dec'16 | ||||
|---|---|---|---|---|---|---|
Cash flows from operating activities: | ||||||
Net loss | ||||||
-82,057 | -53,212 | -44,709 | ||||
Adjustments to reconcile net loss to net cash used in operating activities: | ||||||
Depreciation and amortization expense | ||||||
7,965 | 7,089 | 7,932 | ||||
Stock-based compensation expense | ||||||
13,576 | 8,956 | 7,356 | ||||
Provisions for doubtful accounts | ||||||
284 | -347 | 417 | ||||
Non-cash interest expense | ||||||
47 | 22 | 165 | ||||
Change in fair value of warrant liability | ||||||
8,838 | 810 | -11 | ||||
Loss on extinguishment of debt | ||||||
- | - | -161 | ||||
Deferred income taxes | ||||||
-468 | -31 | -2,366 | ||||
Other non-cash income | ||||||
560 | - | - | ||||
Changes in operating assets and liabilities: | ||||||
Accounts receivable | ||||||
1,990 | 16,901 | 13,737 | ||||
Prepaid expenses and other assets | ||||||
2,786 | 867 | 2,645 | ||||
Deferred commissions | ||||||
8,199 | 8,263 | 7,390 | ||||
Accounts payable | ||||||
2,229 | -696 | 991 | ||||
Accrued expenses | ||||||
1,824 | 4,202 | 3,537 | ||||
Deferred revenue | ||||||
24,194 | 52,017 | 31,169 | ||||
Management incentive plan liability | ||||||
- | - | -13,985 | ||||
Deferred rent | ||||||
-191 | -394 | 360 | ||||
Other long-term liabilities | ||||||
-1 | -63 | -333 | ||||
Net cash used in operating activities | ||||||
-37,295 | -7,678 | -33,088 | ||||
Cash flows from investing activities: | ||||||
Purchases of short-term investments | ||||||
96,558 | - | - | ||||
Sale and maturities of short-term investments | ||||||
4,300 | - | - | ||||
Purchases of property and equipment | ||||||
6,041 | 5,145 | 5,776 | ||||
Net cash received in (paid for) business acquisitions | ||||||
- | - | 8,884 | ||||
Capitalization of internal-use software costs | ||||||
2,319 | 922 | 411 | ||||
Cash paid to former stockholders of Confer | ||||||
- | - | 2,000 | ||||
Net cash provided by (used in) investing activities | ||||||
-100,618 | -6,067 | 697 | ||||
Cash flows from financing activities: | ||||||
Proceeds from issuance of Series F preferred stock, net of issuance costs | ||||||
- | - | 13,385 | ||||
Proceeds from issuance of Series F preferred stock options upon exercise of the Customer Option in connection with acquisition of Confer | ||||||
- | - | 2,000 | ||||
Proceeds from exercise of stock options | ||||||
10,138 | 3,902 | 2,467 | ||||
Payments of deferred financing costs | ||||||
47 | 84 | - | ||||
Repayments of line of credit | ||||||
- | 5,500 | 94 | ||||
Repayment of borrowed funds | ||||||
- | - | 6,000 | ||||
Proceeds from line of credit | ||||||
- | - | 5,500 | ||||
Proceeds from initial public offering, net of offering costs | ||||||
159,617 | - | - | ||||
Payments of initial public offering costs | ||||||
- | 3 | 1,863 | ||||
Net cash provided by financing activities | ||||||
169,708 | -1,685 | 15,395 | ||||
Net (decrease) increase in cash and cash equivalents | ||||||
31,795 | -15,430 | -16,996 | ||||
Supplemental Cash Flow Information [Abstract] | ||||||
Cash paid for interest | ||||||
61 | 127 | 543 | ||||
Supplemental disclosure of non-cash investing and financing activities: | ||||||
Conversion of redeemable convertible preferred stock upon initial public offering | ||||||
532,696 | - | - | ||||
Conversion of convertible preferred stock upon initial public offering | ||||||
1,721 | - | - | ||||
Issuance of common stock upon exercise of common stock warrants | ||||||
11,604 | - | - | ||||
Deferred IPO costs paid in prior periods | ||||||
1,911 | - | - | ||||
Accretion of preferred stock to redemption value | ||||||
199,492 | 28,056 | 3,569 | ||||
Additions to property and equipment included in accounts payable at period end | ||||||
243 | 290 | 173 | ||||
Deferred offering costs included in accounts payable at period end | ||||||
- | 257 | 1 | ||||
Series E preferred stock issued in connection with an acquisition | ||||||
- | - | 507 | ||||
Series F preferred stock, common stock, common stock options, Customer Option and Customer Warrant issued in connection with acquisition of Confer | ||||||
- | 1,347 | 99,941 | ||||
Issuance of common stock as partial settlement of management incentive plan liability | ||||||
- | - | 6,015 | ||||
Series B preferred stock issued upon exercise of Series B Warrant | ||||||
- | 225 | - | ||||